AL
Alector, Inc.
ALEC · NASDAQ
$2.04 -7.08% (-$0.15)
1M -0.49%
Market Cap $225.9M
P/E Ratio -
Div. Yield -
ROE 531.04%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 16.30x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Rev. growth 46.00%
Book val. growth 47.72%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 360.92%
FCF margin 1,142.55%
Net margin 850.13%
Quality
1 /100
Poor ROIC 67.73%
Asset turnover 0.07x
ROE 531.04%
Debt
100 /100
Low Current ratio 5.26x
Debt/Equity N/A
Debt/Assets N/A
Stability
53 /100
Moderate Beta 0.58x
Profitable years 0
Rev. volatility 41.77%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ALEC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Arnon Rosenthal
Employees
103
Headquarters
South San Francisco
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report